Browse current Insitro openings that JobDrop found directly from the company's careers source.
Associate Scientist III, wanted by Insitro, Inc. in South San Francisco, CA. Onboarding new cell models and developing quality control metrics for automated high-throughput arrayed genetic and compounding cell-screening assays suitable for downstream machine learning based discovery; Preparing, optimizing, and implemen
The Opportunity insitro is a physical AI company dedicated to unlocking causal human biology and accelerating the delivery of better medicines to patients. Our unique Virtual Human™ platform identifies novel, high-impact genetic intervention points, which our TherML™ platform translates into therapeutics—whether small
The Opportunity insitro is a physical AI company dedicated to unlocking causal human biology and accelerating the delivery of better medicines to patients. Our unique Virtual Human™ platform identifies novel, high-impact genetic intervention points, which our TherML™ platform translates into therapeutics—whether small
The Opportunity The unprecedented convergence of multi-modal data, advanced disease modeling, and computational power is revolutionizing drug discovery. insitro is harnessing this moment to redefine how medicines are developed for complex diseases. Our AI/ML-enabled platforms integrate and scale data to rapidly discove
The Opportunity insitro's mission is to bring better drugs faster to patients who can benefit most, through machine learning and data at scale. Our discovery strategy integrates insights from multiple phenotypic readouts across diverse high-content data modalities, including data from public and proprietary human cohor
The Opportunity insitro is a physical AI company dedicated to unlocking causal human biology and accelerating the delivery of better medicines to patients. Our unique Virtual Human™ platform identifies novel, high-impact genetic intervention points, which our TherML™ platform translates into therapeutics—whether small
The Opportunity The unprecedented convergence of multi-modal data and AI has the potential to revolutionize drug discovery. insitro is harnessing this moment to redefine how medicines are developed for complex diseases. Our success depends on our ability to attract, develop, inspire, and retain amazing, diverse talent
The Opportunity The unprecedented convergence of multi-modal data, advanced disease modeling, and computational power is revolutionizing drug discovery. insitro is harnessing this moment to redefine how medicines are developed for complex diseases. Our AI/ML-enabled platforms integrate and scale data to rapidly discove
The Opportunity At our company, quality isn’t a hurdle to innovation—it’s the foundation that makes our data-driven insights trustworthy. You will not just be checking boxes; you will be defining the regulatory standards for the future of AI-driven drug discovery. As we transition into clinical-stage operations, we are
The Opportunity State-of-the-art technologies that measure multiple cellular aspects of in-vitro biology are at the heart of insitro's efforts to accelerate drug development. Computational biology is key to elucidating the relationship between these phenotypes and human disease and translating them into actionable outc
The Opportunity Imaging based phenotyping of in-vitro biology is at the heart of insitro's efforts to accelerate drug development. At insitro, we use machine learning to derive clinically relevant insights from rich datasets generated in-house. As an Imaging ML Scientist, you will develop ML-empowered computer vision p
The Opportunity The unprecedented convergence of multi-modal data, advanced disease modeling, and computational power is revolutionizing drug discovery. insitro is harnessing this moment to redefine how medicines are developed for complex diseases. Our AI/ML-enabled platforms integrate and scale data to rapidly discove
The Opportunity At insitro, we're revolutionizing drug development. We fuse cutting-edge machine learning with large-scale biology and modality-independent drug discovery to tackle major bottlenecks in the pipeline. We've built a leading platform and a team of incredibly talented scientists driven to make a real differ